Literature DB >> 2121791

Diagnosis of Mycoplasma pneumoniae pneumonia: sensitivities and specificities of serology with lipid antigen and isolation of the organism on soy peptone medium for identification of infections.

G E Kenny1, G G Kaiser, M K Cooney, H M Foy.   

Abstract

The sensitivities and specificities of isolation and serology for detection of Mycoplasma pneumoniae infections were determined for 3,546 pneumonia patients for whom both isolation and serological data were available. Soy peptone, fresh yeast extract, horse serum-supplemented agar, and diphasic medium were employed for isolation, and the lipid antigen of M. pneumoniae was used for serodiagnosis by complement fixation. The number of M. pneumoniae colonies most frequently detected was 200 to 600 per throat swab, with a range of less than or equal to 60 to greater than or equal to 2,000. The use of diphasic medium increased the number of isolates by 26% compared with direct isolation on agar plates. The organism was isolated from 360 of 525 patients who showed fourfold or greater antibody increases in their paired sera, resulting in a sensitivity of culture of 68%. When persons with titers of greater than or equal to 32 but no fourfold increase were used as the reference, the sensitivity of culture was 58%. The combined sensitivity of the culture method for persons with serological evidence of infection (fourfold increase and titer of greater than or equal to 32) was 64%. The specificity of the culture method was 97% for the 2,527 serologically negative persons. Fourfold antibody increases were found in 360 of 674 persons with isolates of the organism, resulting in a sensitivity of 53%. An additional 247 persons showed titers of greater than or equal to 32 (without a fourfold increase), resulting in a combined sensitivity of 90% for serology with the lipid antigen for the detection of antibodies in culture-positive persons. Fourfold antibody increases were found in 6% of culture-negative persons, resulting in a specificity of 94%. The quantitative culture results provide important base-line data for the development of rapid diagnostic tests for M. pneumoniae infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121791      PMCID: PMC268108          DOI: 10.1128/jcm.28.9.2087-2093.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  36 in total

1.  Recovery of PPLO of atypical pneumonia on artificial agar medium.

Authors:  R M CHANOCK; M A MUFSON; W D JAMES; H H FOX; H H BLOOM; B FORSYTH
Journal:  Proc Soc Exp Biol Med       Date:  1962-07

2.  Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO.

Authors:  R M CHANOCK; L HAYFLICK; M F BARILE
Journal:  Proc Natl Acad Sci U S A       Date:  1962-01-15       Impact factor: 11.205

3.  Isolation and elimination of pleuropneumonia-like organisms from mammalian cell cultures.

Authors:  M E POLLOCK; G E KENNY; J T SYVERTON
Journal:  Proc Soc Exp Biol Med       Date:  1960-10

4.  Investigation of the cultivation of pleuropneumonia-like organisms from man.

Authors:  H E MORTON; P F SMITH; P R LEBERMAN
Journal:  Am J Syph Gonorrhea Vener Dis       Date:  1951-07

5.  DNA probe versus culture for detection of Mycoplasma pneumoniae in clinical specimens.

Authors:  R C Tilton; F Dias; H Kidd; R W Ryan
Journal:  Diagn Microbiol Infect Dis       Date:  1988-06       Impact factor: 2.803

6.  Mycoplasma pneumoniae infections in University of Wisconsin students.

Authors:  A S Evans; V Allen; S Sueltmann
Journal:  Am Rev Respir Dis       Date:  1967-08

7.  Detection of Mycoplasma pneumoniae by using the polymerase chain reaction.

Authors:  C Bernet; M Garret; B de Barbeyrac; C Bebear; J Bonnet
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

8.  Detection of Mycoplasma pneumoniae in simulated clinical samples by polymerase chain reaction. Brief report.

Authors:  J S Jensen; J Søndergård-Andersen; S A Uldum; K Lind
Journal:  APMIS       Date:  1989-11       Impact factor: 3.205

9.  Isolation and characterization of Mycoplasma genitalium strains from the human respiratory tract.

Authors:  J B Baseman; S F Dallo; J G Tully; D L Rose
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

10.  Hemolysis in identifying Eaton's pleuro-pneumonia-like organism.

Authors:  W A CLYDE
Journal:  Science       Date:  1963-01-04       Impact factor: 47.728

View more
  24 in total

1.  Evaluation of Chlamydia pneumoniae and Mycoplasma pneumoniae as etiologic agents of persistent cough in adolescents and adults.

Authors:  Robert M Wadowsky; Elias A Castilla; Stella Laus; Anita Kozy; Robert W Atchison; Lawrence A Kingsley; Joel I Ward; David P Greenberg
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Effect of a Mycoplasma hominis-like Mycoplasma on the infection of HEp-2 cells by the TW-183 strain of Chlamydia pneumoniae.

Authors:  E A Castilla; R M Wadowsky
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 3.  Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections.

Authors:  K Loens; L Van Heirstraeten; S Malhotra-Kumar; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

4.  Molecular approaches to diagnosis of pulmonary diseases due to Mycoplasma pneumoniae.

Authors:  M Abele-Horn; U Busch; H Nitschko; E Jacobs; R Bax; F Pfaff; B Schaffer; J Heesemann
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

5.  Isolation of Mycoplasma genitalium strains from the male urethra.

Authors:  J S Jensen; H T Hansen; K Lind
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

6.  Performance of Meridian ImmunoCard Mycoplasma test in a multicenter clinical trial.

Authors:  T S Alexander; L D Gray; J A Kraft; D S Leland; M T Nikaido; D H Willis
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

7.  Enzyme immunoassay for detection of immunoglobulin M (IgM) and IgG antibodies to Mycoplasma pneumoniae.

Authors:  S A Uldum; J S Jensen; J Søndergård-Andersen; K Lind
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

Review 8.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Comparison of two rapid commercial tests with complement fixation for serologic diagnosis of Mycoplasma pneumoniae infections.

Authors:  W L Thacker; D F Talkington
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

10.  Ten and a half years seroepidemiology of Mycoplasma pneumoniae infection in Denmark.

Authors:  K Lind; M W Bentzon
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.